\-\ Texto\\:\\ \ \(0\)\
\-\ vitals\\:\\ wnl\\,\\ afebrile\\,\\ normotensive\ \(0\)\
\-\ general\\:\\ alert\\,\\ quiet\\ child\\ in\\ no\\ apparent\\ distress\\.\\ \\ physical\\ exam\\ is\\ unremarkable\\.\ \(0\)\
\-\ esr\\:\\ 27\\ mm\\/hr\\ \\(normal\\ 0\\-13\\)\ \(0\)\
\-\ tsh\\,\\ t3\\,\\ free\\ t4\\:\\ wnl\ \(0\)\
\-\ iron\\:\\ wnl\ \(0\)\
\-\ transferrin\\:\\ 190\\ \\(normal\\ 200\\-400\\ mg\\/dl\\)\ \(0\)\
\-\ iron\\ binding\\ capacity\\:\\ 266\\ \\(normal\\ 277\\-437\\ ug\\/dl\\)\ \(0\)\
\-\ cyclic\\ citrullinated\\ peptide\\ antibody\\ \\(igg\\)\\:\\ negative\ \(0\)\
\-\ sickle\\ cell\\ screen\\:\\ negative\ \(0\)\
\-\ hiv\\ 1\\ dna\\ pcr\\:\\ not\\ detected\ \(0\)\
\-\ \\	\ \(2191\)\
\-\ hep\\ b\\ surface\\ antigen\\ and\\ core\\ antibody\\ igm\\:\\ negative\ \(0\)\
\-\ hepatitis\\ c\\ virus\\ antibody\\:\\ negative\ \(0\)\
\-\ hepatitis\\ a\\ \\(igm\\)\\:\\ negative\ \(0\)\
\-\ ppd\\:\\ non\\-reactive\\ \\(2x\\)\ \(0\)\
\-\ referral\\ to\\ infectious\\ disease\\ for\\ signs\\ of\\ infection\\,\\ observation\\ of\\ ectopic\\ kidney\\ with\\ referral\\ to\\ urology\\ if\\ complications\\ or\\ symptoms\\ arise\\.\ \(0\)\
\-\ the\\ terminal\\ ileum\\ appeared\\ somewhat\\ irregular\\,\\ and\\ the\\ adjacent\\ bowel\\ loops\\ were\\ significantly\\ separated\\ from\\ it\\.\\ although\\ this\\ can\\ be\\ seen\\ with\\ inflammatory\\ bowel\\ disease\\ and\\ associated\\ proliferation\\ of\\ the\\ surrounding\\ mesenteric\\ fat\\,\\ lymphoma\\ could\\ also\\ cause\\ this\\ appearance\\ and\\ a\\ ct\\ scan\\ of\\ the\\ abdomen\\ and\\ pelvis\\ with\\ iv\\ and\\ oral\\ contrast\\ is\\ recommended\\.\ \(0\)\
\-\ ct\\ of\\ the\\ abdomen\\ and\\ pelvis\\ with\\ iv\\ contrast\\:\\ \ \(0\)\
\-\ 1\\.\\ right\\ pelvic\\ kidney\\.\\ this\\ displaces\\ adjacent\\ bowel\\ loops\\ and\\ partially\\ effaces\\ the\\ terminal\\ ileum\\,\\ accounting\\ for\\ the\\ abnormalities\\ seen\\ on\\ the\\ small\\ bowel\\ follow\\-through\\.\ \(0\)\
\-\ 2\\.\\ multiple\\ ill\\-defined\\ somewhat\\ nodular\\ opacities\\ in\\ the\\ visualized\\ portions\\ of\\ the\\ right\\ lower\\ lobe\\,\\ right\\ middle\\ lobe\\,\\ left\\ lower\\ lobe\\,\\ and\\ lingula\\.\\ although\\ cannot\\ exclude\\ neoplasia\\,\\ suspect\\ this\\ is\\ more\\ likely\\ to\\ be\\ infectious\\/inflammatory\\.\ \(0\)\
\-\ unilateral\\ \\(right\\)\\ renal\\ ectopia\ \(0\)\
\-\ 1\\.\\	ectopic\\ kidney\ \(0\)\
\-\ 2\\.\\	fused\\ pelvic\\ kidney\ \(0\)\
\-\ 3\\.\\	primary\\ pelvic\\ tumor\ \(0\)\
\-\ 4\\.\\	hydronephrosis\ \(0\)\
\-\ 5\\.\\	uteropelvic\\ junction\\ obstruction\ \(0\)\
\-\ 6\\.\\	duplicate\\ collecting\\ systems\ \(0\)\
\-\ 10\\ y\\.o\\.\\ boy\\ with\\ no\\ significant\\ past\\ medical\\ history\\ who\\ presented\\ with\\ to\\ pcp\\ poor\\ appetite\\,\\ failure\\ to\\ thrive\\,\\ and\\ fatigue\\ for\\ 6\\ weeks\\.\\ \\ he\\ also\\ complained\\ of\\ intermittent\\ fevers\\,\\ unknown\\ amount\\ of\\ weight\\ loss\\,\\ night\\ sweats\\,\\ and\\ vague\\ discomfort\\ in\\ his\\ abdomen\\ and\\ extremities\\.\ \(0\)\
\-\ this\\ patient\\ presented\\ for\\ work\\ up\\ of\\ poor\\ appetite\\,\\ failure\\ to\\ thrive\\,\\ fatigue\\,\\ and\\ weight\\ loss\\ for\\ 6\\ weeks\\.\\ \\ on\\ small\\ bowel\\ follow\\ through\\,\\ the\\ patient\\â\\€\\™s\\ bowel\\ loops\\ were\\ significantly\\ separated\\ from\\ an\\ irregular\\ appearing\\ ileum\\.\\ this\\ prompted\\ further\\ imaging\\ with\\ abdominal\\ and\\ pelvic\\ ct\\ with\\ contrast\\,\\ which\\ incidentally\\ showed\\ right\\ pelvic\\ kidney\\.\\ \\ although\\ the\\ ectopic\\ kidney\\ may\\ have\\ partially\\ caused\\ his\\ symptoms\\,\\ the\\ patient\\ was\\ referred\\ to\\ infectious\\ disease\\ due\\ to\\ the\\ likelihood\\ that\\ the\\ etiology\\ of\\ his\\ symptoms\\ were\\ infections\\ or\\ inflammatory\\.\\ \\ the\\ patients\\ should\\ be\\ monitored\\ for\\ any\\ genitourinary\\ signs\\ in\\ the\\ future\\ with\\ immediate\\ referral\\ to\\ urology\\ should\\ complications\\ arise\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ kidney\\:\\ 0\\.20660998765334615\ \(0\)\
\-\ pelvic\\:\\ 0\\.19157516803228133\ \(0\)\
\-\ bowel\\:\\ 0\\.18873488555001558\ \(0\)\
\-\ antibody\\:\\ 0\\.1680666010641211\ \(0\)\
\-\ the\\:\\ 0\\.16626537124502744\ \(0\)\
\-\ negative\\:\\ 0\\.15172499260005945\ \(0\)\
\-\ referral\\:\\ 0\\.15019882055335534\ \(0\)\
\-\ ileum\\:\\ 0\\.14880508878962823\ \(0\)\
\-\ and\\:\\ 0\\.1417975826718431\ \(0\)\
\-\ wnl\\:\\ 0\\.13790478707907028\ \(0\)\
\-\ loops\\:\\ 0\\.13355296350133192\ \(0\)\
\-\ ectopic\\:\\ 0\\.13004833196621626\ \(0\)\
\-\ igm\\:\\ 0\\.12333127015483485\ \(0\)\
\-\ infectious\\:\\ 0\\.11831785243347714\ \(0\)\
\-\ thrive\\:\\ 0\\.1172017498156012\ \(0\)\
\-\ separated\\:\\ 0\\.11556382796105408\ \(0\)\
\-\ to\\:\\ 0\\.11028341811310607\ \(0\)\
\-\ iron\\:\\ 0\\.10808281193468226\ \(0\)\
\-\ urology\\:\\ 0\\.10758465612119343\ \(0\)\
\-\ appetite\\:\\ 0\\.10288806309181235\ \(0\)\
\-\ this\\:\\ 0\\.10105511002480085\ \(0\)\
\-\ hepatitis\\:\\ 0\\.10078112107170982\ \(0\)\
\-\ terminal\\:\\ 0\\.10078112107170982\ \(0\)\
\-\ although\\:\\ 0\\.10010590448268536\ \(0\)\
\-\ inflammatory\\:\\ 0\\.09943105551447981\ \(0\)\
\-\ of\\:\\ 0\\.09592065049951462\ \(0\)\
\-\ fatigue\\:\\ 0\\.09495164045863037\ \(0\)\
\-\ significantly\\:\\ 0\\.09213519944338276\ \(0\)\
\-\ abdomen\\:\\ 0\\.08972238977462715\ \(0\)\
\-\ arise\\:\\ 0\\.08971599886065784\ \(0\)\
\-\ somewhat\\:\\ 0\\.08920297054756222\ \(0\)\
\-\ his\\:\\ 0\\.08917968008020655\ \(0\)\
\-\ for\\:\\ 0\\.08913685407339271\ \(0\)\
\-\ with\\:\\ 0\\.08638016675879831\ \(0\)\
\-\ lobe\\:\\ 0\\.08497688397013865\ \(0\)\
\-\ partially\\:\\ 0\\.08413320532629934\ \(0\)\
\-\ poor\\:\\ 0\\.08269024580820913\ \(0\)\
\-\ right\\:\\ 0\\.08125289658315148\ \(0\)\
\-\ symptoms\\:\\ 0\\.08045508440579457\ \(0\)\
\-\ transferrin\\:\\ 0\\.07838603559846516\ \(0\)\
\-\ citrullinated\\:\\ 0\\.07838603559846516\ \(0\)\
\-\ uteropelvic\\:\\ 0\\.07838603559846516\ \(0\)\
\-\ duplicate\\:\\ 0\\.07838603559846516\ \(0\)\
\-\ were\\:\\ 0\\.07579781606623519\ \(0\)\
\-\ irregular\\:\\ 0\\.07568385545945946\ \(0\)\
\-\ complications\\:\\ 0\\.07508080508496869\ \(0\)\
\-\ 266\\:\\ 0\\.07490204174182707\ \(0\)\
\-\ failure\\:\\ 0\\.07442674496028351\ \(0\)\
\-\ contrast\\:\\ 0\\.07144650957942358\ \(0\)\
\-\ quiet\\:\\ 0\\.07051272858164445\ \(0\)\
\-\ cyclic\\:\\ 0\\.07051272858164445\ \(0\)\
\-\ peptide\\:\\ 0\\.07051272858164445\ \(0\)\
\-\ hep\\:\\ 0\\.07051272858164445\ \(0\)\
\-\ iv\\:\\ 0\\.07004459515033523\ \(0\)\
\-\ binding\\:\\ 0\\.06894611490490514\ \(0\)\
\-\ 2x\\:\\ 0\\.06894611490490514\ \(0\)\
\-\ pelvis\\:\\ 0\\.06856310965393628\ \(0\)\
\-\ signs\\:\\ 0\\.06851249055335315\ \(0\)\
\-\ weight\\:\\ 0\\.06836152174448774\ \(0\)\
\-\ effaces\\:\\ 0\\.06647418192462132\ \(0\)\
\-\ should\\:\\ 0\\.0639648789193804\ \(0\)\
\-\ adjacent\\:\\ 0\\.06354337084507704\ \(0\)\
\-\ capacity\\:\\ 0\\.06299018806798322\ \(0\)\
\-\ 190\\:\\ 0\\.06230241420969876\ \(0\)\
\-\ dna\\:\\ 0\\.06230241420969876\ \(0\)\
\-\ pcr\\:\\ 0\\.06230241420969876\ \(0\)\
\-\ disease\\:\\ 0\\.06172456641605625\ \(0\)\
\-\ normotensive\\:\\ 0\\.06166563507741742\ \(0\)\
\-\ suspect\\:\\ 0\\.060518255087699396\ \(0\)\
\-\ normal\\:\\ 0\\.06003777857563329\ \(0\)\
\-\ antigen\\:\\ 0\\.05999733280426306\ \(0\)\
\-\ lingula\\:\\ 0\\.05999733280426306\ \(0\)\
\-\ loss\\:\\ 0\\.05972375828019856\ \(0\)\
\-\ be\\:\\ 0\\.05965056713652775\ \(0\)\
\-\ neoplasia\\:\\ 0\\.05904161695676942\ \(0\)\
\-\ weeks\\:\\ 0\\.05875158704715206\ \(0\)\
\-\ through\\:\\ 0\\.05835520635946125\ \(0\)\
\-\ accounting\\:\\ 0\\.05818164122077933\ \(0\)\
\-\ igg\\:\\ 0\\.05778191398052704\ \(0\)\
\-\ genitourinary\\:\\ 0\\.0573999583828281\ \(0\)\
\-\ presented\\:\\ 0\\.05716582053528652\ \(0\)\
\-\ virus\\:\\ 0\\.05634648737277683\ \(0\)\
\-\ ct\\:\\ 0\\.05598168346609291\ \(0\)\
\-\ ppd\\:\\ 0\\.0557097082404955\ \(0\)\
\-\ ectopia\\:\\ 0\\.0557097082404955\ \(0\)\
\-\ pcp\\:\\ 0\\.05483513167497432\ \(0\)\
\-\ displaces\\:\\ 0\\.05404140596734113\ \(0\)\
\-\ prompted\\:\\ 0\\.05404140596734113\ \(0\)\
\-\ likelihood\\:\\ 0\\.05404140596734113\ \(0\)\
\-\ t3\\:\\ 0\\.0530856901198475\ \(0\)\
\-\ follow\\:\\ 0\\.05284693880314192\ \(0\)\
\-\ proliferation\\:\\ 0\\.05264494807087868\ \(0\)\
\-\ monitored\\:\\ 0\\.05264494807087868\ \(0\)\
\-\ fused\\:\\ 0\\.0520235265586133\ \(0\)\
\-\ small\\:\\ 0\\.05056742066259683\ \(0\)\
\-\ screen\\:\\ 0\\.05055741211070304\ \(0\)\
\-\ lower\\:\\ 0\\.050093679944279164\ \(0\)\
\-\ sweats\\:\\ 0\\.050066273517785115\ \(0\)\
\-\ t4\\:\\ 0\\.04916095421424058\ \(0\)\
\-\ core\\:\\ 0\\.04916095421424058\ \(0\)\
\-\ future\\:\\ 0\\.04916095421424058\ \(0\)\
\-\ in\\:\\ 0\\.048773601492248075\ \(0\)\
\-\ sickle\\:\\ 0\\.04847318035595612\ \(0\)\
\-\ hiv\\:\\ 0\\.04847318035595612\ \(0\)\
\-\ appeared\\:\\ 0\\.04847318035595612\ \(0\)\
\-\ vague\\:\\ 0\\.04796003768926808\ \(0\)\
\-\ patient\\:\\ 0\\.04782658852896145\ \(0\)\
\-\ tsh\\:\\ 0\\.04735891249242247\ \(0\)\
\-\ exclude\\:\\ 0\\.04735891249242247\ \(0\)\
\-\ systems\\:\\ 0\\.04735891249242247\ \(0\)\
\-\ complained\\:\\ 0\\.0472435740343418\ \(0\)\
\-\ detected\\:\\ 0\\.047017440296401224\ \(0\)\
\-\ immediate\\:\\ 0\\.04690656667921682\ \(0\)\
\-\ opacities\\:\\ 0\\.046797105503247324\ \(0\)\
\-\ portions\\:\\ 0\\.046582279661147016\ \(0\)\
\-\ seen\\:\\ 0\\.04615195400695749\ \(0\)\
\-\ also\\:\\ 0\\.04611072606501745\ \(0\)\
\-\ observation\\:\\ 0\\.04596826235969009\ \(0\)\
\-\ collecting\\:\\ 0\\.04596826235969009\ \(0\)\
\-\ hydronephrosis\\:\\ 0\\.04548810470898425\ \(0\)\
\-\ discomfort\\:\\ 0\\.045303310788690994\ \(0\)\
\-\ alert\\:\\ 0\\.045122407557217456\ \(0\)\
\-\ esr\\:\\ 0\\.04485799943032892\ \(0\)\
\-\ unilateral\\:\\ 0\\.04485799943032892\ \(0\)\
\-\ night\\:\\ 0\\.0440311517782139\ \(0\)\
\-\ vitals\\:\\ 0\\.043276932283215316\ \(0\)\
\-\ fevers\\:\\ 0\\.043276932283215316\ \(0\)\
\-\ infections\\:\\ 0\\.043276932283215316\ \(0\)\
\-\ afebrile\\:\\ 0\\.04232121643572168\ \(0\)\
\-\ mesenteric\\:\\ 0\\.04232121643572168\ \(0\)\
\-\ incidentally\\:\\ 0\\.041758591689123936\ \(0\)\
\-\ apparent\\:\\ 0\\.041005897821231686\ \(0\)\
\-\ surface\\:\\ 0\\.04089573495189595\ \(0\)\
\-\ child\\:\\ 0\\.04057347520435851\ \(0\)\
\-\ is\\:\\ 0\\.04026946749415886\ \(0\)\
\-\ intermittent\\:\\ 0\\.040061860651868245\ \(0\)\
\-\ work\\:\\ 0\\.03996309420685408\ \(0\)\
\-\ 27\\:\\ 0\\.039721033520680564\ \(0\)\
\-\ distress\\:\\ 0\\.03948560547560175\ \(0\)\
\-\ etiology\\:\\ 0\\.03948560547560175\ \(0\)\
\-\ general\\:\\ 0\\.03934738395176907\ \(0\)\
\-\ caused\\:\\ 0\\.0393017998336593\ \(0\)\
\-\ oral\\:\\ 0\\.03925645626610487\ \(0\)\
\-\ junction\\:\\ 0\\.03925645626610487\ \(0\)\
\-\ amount\\:\\ 0\\.03921135072362313\ \(0\)\
\-\ appearing\\:\\ 0\\.03916648072029553\ \(0\)\
\-\ nodular\\:\\ 0\\.039033259662396104\ \(0\)\
\-\ recommended\\:\\ 0\\.038989307719447766\ \(0\)\
\-\ from\\:\\ 0\\.03893354870277772\ \(0\)\
\-\ visualized\\:\\ 0\\.03827459783248584\ \(0\)\
\-\ free\\:\\ 0\\.038154419843941266\ \(0\)\
\-\ extremities\\:\\ 0\\.03724910054039675\ \(0\)\
\-\ unknown\\:\\ 0\\.037142358967587004\ \(0\)\
\-\ referred\\:\\ 0\\.03626892313703086\ \(0\)\
\-\ could\\:\\ 0\\.03565270317313902\ \(0\)\
\-\ abnormalities\\:\\ 0\\.03550531386280967\ \(0\)\
\-\ middle\\:\\ 0\\.035049970984309765\ \(0\)\
\-\ obstruction\\:\\ 0\\.03433239868011913\ \(0\)\
\-\ or\\:\\ 0\\.03410305676617277\ \(0\)\
\-\ boy\\:\\ 0\\.03352967863867983\ \(0\)\
\-\ cause\\:\\ 0\\.033391457114847145\ \(0\)\
\-\ unremarkable\\:\\ 0\\.032859787380214125\ \(0\)\
\-\ surrounding\\:\\ 0\\.03268963159993727\ \(0\)\
\-\ showed\\:\\ 0\\.03264761398021283\ \(0\)\
\-\ further\\:\\ 0\\.031924446532388275\ \(0\)\
\-\ past\\:\\ 0\\.03190520221054455\ \(0\)\
\-\ no\\:\\ 0\\.03187839508431172\ \(0\)\
\-\ any\\:\\ 0\\.03167757072358301\ \(0\)\
\-\ medical\\:\\ 0\\.031151144253095647\ \(0\)\
\-\ renal\\:\\ 0\\.03052317351329406\ \(0\)\
\-\ fat\\:\\ 0\\.03049050204385029\ \(0\)\
\-\ primary\\:\\ 0\\.030139083376741385\ \(0\)\
\-\ infection\\:\\ 0\\.02960803971854942\ \(0\)\
\-\ on\\:\\ 0\\.029606886187043963\ \(0\)\
\-\ appearance\\:\\ 0\\.029549387025887747\ \(0\)\
\-\ likely\\:\\ 0\\.029290294448882023\ \(0\)\
\-\ lymphoma\\:\\ 0\\.029191609028164166\ \(0\)\
\-\ scan\\:\\ 0\\.029080196302148042\ \(0\)\
\-\ he\\:\\ 0\\.02902502702041655\ \(0\)\
\-\ 10\\:\\ 0\\.028661621530514658\ \(0\)\
\-\ if\\:\\ 0\\.028479071105302435\ \(0\)\
\-\ significant\\:\\ 0\\.02830031843975465\ \(0\)\
\-\ due\\:\\ 0\\.02817487699860352\ \(0\)\
\-\ cell\\:\\ 0\\.028038974169597292\ \(0\)\
\-\ who\\:\\ 0\\.027726044294674887\ \(0\)\
\-\ patients\\:\\ 0\\.02757375180175791\ \(0\)\
\-\ more\\:\\ 0\\.026914607994488887\ \(0\)\
\-\ abdominal\\:\\ 0\\.02680773365510784\ \(0\)\
\-\ physical\\:\\ 0\\.026577187027189694\ \(0\)\
\-\ associated\\:\\ 0\\.025834705861456073\ \(0\)\
\-\ imaging\\:\\ 0\\.025759166156381318\ \(0\)\
\-\ can\\:\\ 0\\.025721643886661084\ \(0\)\
\-\ tumor\\:\\ 0\\.025637813113323936\ \(0\)\
\-\ it\\:\\ 0\\.02509021505723725\ \(0\)\
\-\ exam\\:\\ 0\\.02467429513273739\ \(0\)\
\-\ may\\:\\ 0\\.024666013121386308\ \(0\)\
\-\ have\\:\\ 0\\.024485799752713627\ \(0\)\
\-\ up\\:\\ 0\\.024245991087549348\ \(0\)\
\-\ multiple\\:\\ 0\\.02397441948703915\ \(0\)\
\-\ which\\:\\ 0\\.02228771622330169\ \(0\)\
\-\ that\\:\\ 0\\.021270774978218665\ \(0\)\
\-\ not\\:\\ 0\\.01935004986110323\ \(0\)\
\-\ an\\:\\ 0\\.01874326233383095\ \(0\)\
\-\ history\\:\\ 0\\.018726658297530882\ \(0\)\
\-\ was\\:\\ 0\\.017082295583257086\ \(0\)\
\-\ left\\:\\ 0\\.016720166573805522\ \(0\)\
